{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:48:07Z","timestamp":1761176887514,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.tracli.2017.06.007","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T02:16:03Z","timestamp":1498184163000},"page":"232-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dans la dr\u00e9panocytose, la greffe est-elle une alternative \u00e0 l\u2019impasse transfusionnelle\u00a0?"],"prefix":"10.1016","volume":"24","author":[{"given":"F.","family":"Bernaudin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kuentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2017.06.007_bib0155","first-page":"13","article-title":"Neonatal screening for sickle cell anaemia in metropolitan France. For the group for neonatal screening of sickle cell anemia of the French Association for Screening and Prevention of Infant Handicaps (AFDPHE)]","volume":"47","author":"Galact\u00e9ros","year":"1999","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.tracli.2017.06.007_bib0160","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anaemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2017.06.007_bib0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00043426-199707000-00009","article-title":"Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease","volume":"19","author":"de Montalembert","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tracli.2017.06.007_bib0170","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"BABY HUG investigators. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2017.06.007_bib0175","first-page":"1427","article-title":"Bone marrow transplantation in five children with sickle cell anaemia","volume":"1","author":"Vermylen","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2017.06.007_bib0180","first-page":"118","article-title":"Bone marrow transplantation (BMT) in 14\u00a0children with severe sickle cell disease (SCD): the French experience. GEGMO","volume":"12","author":"Bernaudin","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tracli.2017.06.007_bib0185","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199608083350601","article-title":"Bone marrow transplantation for sickle cell disease","volume":"335","author":"Walters","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2017.06.007_bib0190","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2010-06-293514","article-title":"Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anaemia cohort","volume":"117","author":"Bernaudin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.007_bib0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/003335491312800206","article-title":"Mortality rates and age at death from sickle cell disease: U.S.1979-2005","volume":"128","author":"Lanzkron","year":"2013","journal-title":"Public Health Rep"},{"key":"10.1016\/j.tracli.2017.06.007_bib0200","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199202273260905","article-title":"The use of transcranial ultrasonography to predict stroke in sickle cell disease","volume":"326","author":"Adams","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2017.06.007_bib0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2017.06.007_bib0210","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.007_bib0215","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD with transfusions changing to hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2017.06.007_bib0220","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1182\/blood-2015-10-675231","article-title":"Long-term treatment follow-up of children with sickle cell disease monitored with abnormal transcranial Doppler velocities","volume":"127","author":"Bernaudin","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.007_bib0225","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1246-7820(03)00042-9","article-title":"Immunohematologic characteristics in the Afro-caribbean population. Consequences for transfusion safety","volume":"10","author":"Noizat-Pirenne","year":"2003","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2017.06.007_bib0230","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.007_bib0235","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.007_bib0240","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","article-title":"SFGM-TC. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease","volume":"110","author":"Bernaudin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.007_bib0245","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.V122.21.971.971","article-title":"Relation Between ATG, chimerism, GvHD and outcome in myeloablative genoidentical transplants for the SFGM-TC","volume":"122","author":"Bernaudin","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.007_bib0250","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1083-8791(03)00192-7","article-title":"Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anaemia and beta-thalassemia","volume":"9","author":"Iannone","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2017.06.007_bib0255","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMoa0904971","article-title":"Allogeneic hematopoietic stem-cell transplantation for sickle cell disease","volume":"361","author":"Hsieh","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2017.06.007_bib0260","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype","volume":"312","author":"Hsieh","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.tracli.2017.06.007_bib0265","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbmt.2015.08.036","article-title":"Nonmyeloablative Stem cell transplantation with alemtuzumab\/low-dose irradiation to cure and improve the quality of life of adults with sickle cell disease","volume":"22","author":"Saraf","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2017.06.007_bib0270","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","article-title":"HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease","volume":"120","author":"Bola\u00f1os-Meade","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.007_bib0275","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.V128.22.1233.1233","article-title":"Haploidentical bone marrow transplant with post-transplant cytoxan plus thiotepa improves donor engraftment in patients with sickle cell anaemia: results of an international multicenter learning collaborative","volume":"128","author":"Dhedin","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.007_bib0280","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.bbmt.2012.01.019","article-title":"Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the blood and marrow transplant clinical trials network (BMT CTN)","volume":"18","author":"Kamani","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tracli.2017.06.007_bib0285","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1182\/blood-2016-05-715870","article-title":"A trial of unrelated donor marrow transplantation for children with severe sickle cell disease","volume":"128","author":"Shenoy","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.007_bib0290","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.V98.6.1687","article-title":"Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation","volume":"98","author":"Bolan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.007_bib0295","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1365-2141.2003.04128.x","article-title":"Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation","volume":"120","author":"Lee","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2017.06.007_bib0150","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/sj.bmt.1704524","article-title":"Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation","volume":"33","author":"Franchini","year":"2004","journal-title":"Bone Marrow Transplant"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782017300885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782017300885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:36:29Z","timestamp":1761129389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782017300885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1246782017300885"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2017.06.007","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dans la dr\u00e9panocytose, la greffe est-elle une alternative \u00e0 l\u2019impasse transfusionnelle\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2017.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}